CAS and the Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life science and healthcare R&D, have launched a new Pistoia Alliance Chemical Safety Library platform. This resource aims to mitigate the serious risks researchers working with potentially hazardous chemicals face due to unanticipated chemical reaction outcomes by enabling scientists […]

Author Julia Milzer, CU Anschutz  The CU Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz has announced a new drug discovery technology that can cut the screening time for new drug therapies by half. It will enable rapid and cost-effective screening of hundreds of thousands of potential therapies for diseases. The University of […]

hVIVO, has signed a contract with the UK government to develop a COVID-19 (SARS-CoV-2) human challenge study model. The model development involves the manufacture of the challenge virus and the first-in-human characterisation study for this virus. The contract starts immediately and could be worth approximately £10 million to hVIVO – a subsidiary of Open Orphan […]

The Analytica conference accompanies Analytica 2020, which is currently taking place virtually until 23 October. Key topics in focus at the event are  antibiotic resistance and the ‘laboratory of the future’. The number of microbes that are resistant to certain classes of antibiotics is increasing – hampering therapy. Humans and animals introduce germs and antibiotic-resistant […]

If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will show you how advanced flow cytometry can be used to effectively evaluate immuno-oncology drugs using physiologically relevant assays. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will be hosted by DDW and […]

The world’s first participants to take part in a phase III trial of the Novavax COVID-19 vaccine candidate have  been recruited at one of the new NIHR National Patient Recruitment Centres (NPRC) based in Blackpool, UK. US-based biotechnology firm, Novavax, launched the phase III clinical trial of a potential COVID-19 vaccine, NVX-CoV2373, in the UK […]

Evotec’s Seattle-based subsidiary, Just–Evotec Biologics has received a grant from the Bill & Melinda Gates Foundation as part of the COVID-19 Therapeutics Accelerator to enable the development and production of monoclonal antibody (mAb) candidates for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries. Under the grant, Just–Evotec Biologics will […]

In response to the data management needs of manufacturing QA/QC and contract laboratories, the latest version of Thermo Scientific’s SampleManager Laboratory Information Management System (LIMS) software offers an advanced solution: a built-in electronic lab notebook (ELN), capabilities to streamline operations within contract laboratories and enhanced dashboard configuration for tailored data visualisation. SampleManager LIMS software 12.3 […]

DDW has expanded. The longstanding first-choice publication for the drug discovery and development community now offers more content as well as more ways for you to access it. You told us what you wanted and we listened Established in 1999, DDW is the go-to brand for the industry. Following a reader survey earlier this year, […]

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 and merit advancement into larger clinical trials. The ACTIV-5 Big Effect Trial, which will enrol adult volunteers […]